Browse Studies — Arctuva

Phase 2

A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor

This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in p…

Central Nervous System Nongerminomatous Germ Cell TumorChoriocarcinomaEmbryonal Carcinoma+7 more

Estimated

~$10 – $7,500

Children's Oncology GroupNCT04684368

Phase 2

A Phase II Trial Evaluating Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients With Central Nervous System Germinomas

This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous syst…

Basal Ganglia GerminomaDiabetes InsipidusGerminoma+3 more

Estimated

~$10 – $7,500

Children's Oncology GroupNCT06368817

Phase 1

Phase 1 Trial of Pedmark in Men Receiving Cisplatin for Metastatic Germ Cell Tumor

This phase I trial evaluates whether adding Pedmark to standard of care cisplatin-based chemotherapy reduces drug-induced ear damage (ototoxicity) in men with …

Hearing LossMetastatic Malignant Germ Cell TumorMetastatic Malignant Nongerminomatous Germ Cell Tumor+4 more

Estimated

~$10 – $6,250

City of Hope Medical CenterNCT07218913

Pediatric Germ Cell Tumors: Outcomes, Genomics and Epigenetics

A Non-Therapeutic Study that aims to establish a cohort of GCT survivors to understand short term and long-term adverse effects of treatment and to conduct mol…

Germ Cell TumorGerminomaTeratoma+6 more

Estimated

~$10 – $1,125

Children's Oncology GroupNCT05564026